| ID | 344 |
|---|
| No | 344 |
|---|
| Brand Name | CABOCARE 80 |
|---|
| Ingredients | CABOZANTINIB (S)-MALATE EQ.TO CABOZANTINIB 80 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 30'S/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA IN TREATMENT NAIVE ADULTS WITH INTERMEDIATE OR POOR RISK, IN ADULTS FOLLOWING PRIOR VASCULAR ENDOTHELIAL GROUTH FACTOR TARGETED THERAPY, AS MONOTHERAPYFOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA IN ADULTS WHO HAVE PREVIOUSLY BEEN TREATED WITH SORAFENIB |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | CAPSULE CONTAINS WHITE OR OFF WHITE POWDER |
|---|
| Note | |
|---|
| License Owner | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Manufacturer | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 03 L 0853/21 |
|---|
| FDD Registration Date | 20-FEB-2025 |
|---|
| Expiry Date | 19-FEB-2030 |
|---|
